INmune Bio (NASDAQ:INMB) announced on Monday a partnership with U.K.-based drug technology organization Cell and Gene Therapy Catapult to expand the manufacturing capabilities for its pipeline of cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback